Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Clin Breast Cancer. 2020 Oct 5;21(3):199–204. doi: 10.1016/j.clbc.2020.09.015

Table 3.

Adverse Events Grade ≥ 3 Observed in 5 of 38 Patients

Adverse Event Grade, n
4 3
Syncope 0 1
Back pain 0 1
Fatigue 0 2
Dehydration 0 1
Thrombocytopenia 0 1
Neutropenia 1 0
Diarrhea 0 1
Hand-foot syndrome 0 1
Infusion reaction 0 1